Northern Trust’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-18,200
| Closed | -$71.3K | – | 4629 |
|
|
2023
Q3 | $71.3K | Buy |
+18,200
| New | +$71.3K | ﹤0.01% | 4084 |
|
|
2023
Q2 | – | Sell |
-4,717
| Closed | -$17K | – | 4615 |
|
|
2023
Q1 | $17K | Sell |
4,717
-32
| -0.7% | -$116 | ﹤0.01% | 4474 |
|
|
2022
Q4 | $153K | Sell |
4,749
-15
| -0.3% | -$483 | ﹤0.01% | 3966 |
|
|
2022
Q3 | $199K | Buy |
4,764
+1,157
| +32% | +$48.3K | ﹤0.01% | 3878 |
|
|
2022
Q2 | $152K | Sell |
3,607
-10,742
| -75% | -$453K | ﹤0.01% | 4021 |
|
|
2022
Q1 | $973K | Sell |
14,349
-673
| -4% | -$45.6K | ﹤0.01% | 3428 |
|
|
2021
Q4 | $1.82M | Buy |
15,022
+115
| +0.8% | +$14K | ﹤0.01% | 3261 |
|
|
2021
Q3 | $2.1M | Sell |
14,907
-1,226
| -8% | -$173K | ﹤0.01% | 3264 |
|
|
2021
Q2 | $4.43M | Buy |
16,133
+3,389
| +27% | +$931K | ﹤0.01% | 2910 |
|
|
2021
Q1 | $2.73M | Buy |
12,744
+1,335
| +12% | +$286K | ﹤0.01% | 3085 |
|
|
2020
Q4 | $2.76M | Buy |
11,409
+241
| +2% | +$58.3K | ﹤0.01% | 3020 |
|
|
2020
Q3 | $1.18M | Buy |
11,168
+2,486
| +29% | +$262K | ﹤0.01% | 3318 |
|
|
2020
Q2 | $851K | Buy |
8,682
+1,207
| +16% | +$118K | ﹤0.01% | 3407 |
|
|
2020
Q1 | $561K | Buy |
7,475
+493
| +7% | +$37K | ﹤0.01% | 3419 |
|
|
2019
Q4 | $567K | Buy |
6,982
+32
| +0.5% | +$2.6K | ﹤0.01% | 3529 |
|
|
2019
Q3 | $847K | Sell |
6,950
-10
| -0.1% | -$1.22K | ﹤0.01% | 3435 |
|
|
2019
Q2 | $1.25M | Buy |
6,960
+110
| +2% | +$19.8K | ﹤0.01% | 3287 |
|
|
2019
Q1 | $1.1M | Buy |
6,850
+442
| +7% | +$70.7K | ﹤0.01% | 3330 |
|
|
2018
Q4 | $1.67M | Buy |
6,408
+3,491
| +120% | +$908K | ﹤0.01% | 3148 |
|
|
2018
Q3 | $711K | Buy |
2,917
+1,955
| +203% | +$477K | ﹤0.01% | 3558 |
|
|
2018
Q2 | $227K | Buy |
+962
| New | +$227K | ﹤0.01% | 3817 |
|